Cross-disease approaches to treating the onset, exacerbation and progression of chronic lung diseases

DAY 3

Chaired by: Professor David Lomas (London) and Dr Samantha Walker (ALUK)

1:45 pm	New and known pathological pathways as novel targets during the early phases of chronic respiratory disease Dr Renata Jurkowska (Cardiff)
2:15 pm	Preventing acute microbial-driven exacerbations from destabilising lung function and worsening chronic disease Dr Aurelie Crabbe (Belgium)
2:45 pm	Opportunities for targeting common cross-disease mechanisms to prevent progression of chronic lung diseases Dr Amanda Tatler (Nottingham)

1:45 PM

90 MINUTE SESSION

Learning objectives

Explore common pathways and targets, with treatment potential across different stages of chronic respiratory disease, where focused research would accelerate drug discovery.
Understand how increased efforts in developing specific research tools are needed to make significant progress towards the development of new treatments, including increased effort towards biomarker development across respiratory diseases.
Provide insight into how taking a cross-disease and cross-discipline approach can facilitate collaborations that drive the development of tools (biomarkers) and treatments (drugs) that are truly disease-modifying, and what key elements can drive impactful collaborations.